A new study suggests a medicine cabinet mainstay could be helpful in reducing the risk of colorectal cancer coming back. A small dose of aspirin was shown to halve recurrences of colorectal cancer in ...
A common over-the-counter medication could significantly reduce the risk of colorectal cancer coming back. In a Swedish study, a low dose of aspirin was shown to slash recurrence in half for patients ...
A Swedish-led research team at Karolinska Institutet and Karolinska University Hospital has shown in a new randomized clinical trial that a low dose of the well-known medicine aspirin halves the risk ...
Low-dose aspirin reduced colorectal cancer (CRC) recurrence rates by more than half in patients with tumors harboring mutations in the PI3K signaling pathway, according to findings from the phase 3 ...
An experimental cancer vaccine has shown promise in keeping certain cancers from coming back. In a phase 1 clinical trial led in part by the UCLA Health Jonsson Comprehensive Cancer Center, ...
Hosted on MSN
New Study Suggests Over-The-Counter Medicine Can Reduce Recurrence Of Colorectal Cancer
A new study published in the Journal of Clinical Oncology suggests that a common over-the-counter drug may significantly reduce the risk of colorectal cancer recurrence in patients previously ...
SAN FRANCISCO -- In an era dominated by pricey, high-tech drugs, the humble aspirin had a practice-changing impact on colorectal cancer (CRC) recurrence, according to a randomized study reported here.
* Robotic surgery reduced 3-year cancer recurrence to 1.6% vs 4.0% with laparoscopy * Patients had better urinary, sexual, and bowel function with robotic surgery * Disease-free //survival also ...
Low-dose aspirin significantly reduced colorectal cancer recurrence in patients with PI3K pathway gene alterations, nearly halving recurrence rates over three years compared to placebo. The study ...
Though still uncommon, rectal cancer is on the rise in young adults. Aug. 23, 2010— -- Rectal cancer is on the rise in American men and women under 40 -- although it remains uncommon, researchers ...
Patients with secondary rectal cancer after prostate cancer radiation therapy may have worse survival than patients with primary rectal cancer. Secondary rectal cancer after prostate cancer radiation ...
A Swedish-led research team at Karolinska Institutet and Karolinska University Hospital has shown in a new randomized clinical trial that a low dose of the well-known medicine aspirin halves the risk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results